AstraZeneca 79% effective in preventing symptomatic COVID-19, company says

AstraZeneca said in a statement early Monday the Phase III trial of its COVID-19 vaccine –which was conducted in the U.S.—showed a 79% effectiveness in preventing symptomatic infections and a 100% efficacy “at preventing severe disease and hospitalization.”

from FOX News https://ift.tt/3s8CgeU